Chorokbaem - makes broadcasting contents

Chorokbaem (Green Snake) - makes broadcasting contents
http://www.chorokbaem.com
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20160516001444

The broadcasting business mainly makes profits by producing some programs and delivering it to the broadcasting station. To produce these programs, we require an accumulated know-how in the business field not only a high quality of human resources, so I want to evaluate that the potential of Chorokbaem is high.

The table below shows sales composition of Chorokbaem.

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20160516001444


Next, let's see the major works of Chorokbaem.

SBS dramas and sitcoms
올인,  로비스트,  때려,  2004 신인간시장,  일지매,  도롱뇽도사와 그림자 조작단,  귀엽거나 미치거나

MBC dramas and sitcoms
주몽,  불새,  불꽃놀이,  케세라세라,  90일 사랑할 시간,  거침없이 하이킥,
지붕 뚫고 하이킥,  하이킥! 짧은 다리의 역습,  크크섬의 비밀

KBS dramas
바람의 나라,  추노,  오작교 형제들,  전우치,  프로듀사

tvN dramas and sitcoms
인현왕후의 남자,  나인,  고교처세왕,  삼총사,  하트 투 하트,  오 나의 귀신님,  감자별 2013QR3,  또 오해영

As you can see, there are a lot of popular dramas and sitcoms.


The future of Chorokbaem

Until now, the outsourcing companies such as Chorokbaem have been losing ground. Outsourcing productions have produced programs financially sponsored by broadcasting stations, so it was difficult for them to claim their beneficiary right against the contractors.

However, on October 1, 2015, outsourcing productions should have produced ready-made programs after China, which has a bigger broadcasting market than Korea, has changed deliberation process from deliberating step by step along as a program broadcast to deliberating the whole series of a program at once. To this end, outsourcing productions have begun to replace their financial support from domestic broadcasting stations to Chinese huge capitals, making them that they don't need to watch out for contractors any more.

replace production costs that they have received from broadcasting stations with Chinese giant capital, which is why there is no need to look at the broadcasters' original minds in contract negotiations.

A production NEW, which produced 태양의 후예, can be a good example. NEW and KBS paid for the production expenses on a fifty-fifty basis, but they shared the profits on a sixty-forty basis.

Also, from July 28, 2016, indirect advertising for outsourcing productions will be allowed. This makes it more easier for outsourcing productions to directly sell indirect advertisements, finally allowing that they can create creative advertisements and find the financial resources, which are needed to produce broadcasting contents.

Ultimately, the Fin Syn Rule of the United States, which prohibits contractors from having publication rights of programs created by outsourcing productions, will also also be applied to Korea, so that unnecessarily powerful influence of broadcasters will be weakened. I hope that the rights of various program providers will eventually be guaranteed.

SGA Solutions - electronic security business

SGA Solutions - electronic security business
http://www.sgasol.kr
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20160513004740

SGA Solutions has three businesses as you see below.
1. Server security - develops server security solution and build integrated security system
2. Application security - provides digital signature (PKI) based authentication, application security, and electronic document solution
3. Physical security - sells Motorola solution, Radio solutions


Server security business
The core of server security technology is to provide network control, user control, file and process control, hacking blocking, and log management on operating systems such as UNIX, LINUX, and WINDOWS. To do this, We have to realize user behavior-based access control at the kernel level of the operating system. SGA Solutions provides a powerful server security solution that can detect and block attacks that are not detected by signature-based security solutions.

For server security, SGA Solutions has RedCastle V4.0 (enables secondary authentication when accessing servers) and AuthCastle (supports PKI, OTP, and ARS authentication) as their products. Based on these two products, they won a contract of "Order Control System Construction Project" of the banking sector.


Application security business
They provide one-stop solution about mobile account issuing system of stock firms and email service, which distributes electronic documents by building a certified e-document authority.

In the future, it is expected that all payments will be made in non-ActiveX environment. SGA Solutions will develop FIDO authentication platform, which is the next generation authentication, along with domestic mobile communication company, to meet the paradigm of changing authentication market.


Physical security business
SGA Solutions is planning to supply Motorola's digital radio products with an agreement with SBCK that is an IT distributor in Korea. As analog product licenses expire by 2018 and demand for new digital products will increase, I expect that SGA Solutions will make profits by monopolistic supplying Motorola's entry-level digital products to the market.

K-TOP REITS - provides rental housing in the era of single household

K-TOP REITS - provides rental housing in the era of single household
http://www.ktopreits.co.kr
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20160511002261

REITs stands for Real Estate Investment Trusts, meaning that real estate investment trusts. That are companies or investment trusts that collect funds and invest the collected money in real estate or real estate-related loans.

K-TOP REITS is planning to expand their business to meet the reality of Korea, where the number of single-person households is rapidly increasing. The plan is to supply urban rental housings that are close to the workplace and residential areas. For this purpose, they are gonna make a business agreements with Daiwa House Group in Japan, which is one of the best companies in the rental housing, for five years and acquire know-how.

I think K-TOP REITS has more than 6% of steady dividend rate over the past three years. And I also believe that they set a right direction for the business, so I expect the future of the stock price is quite promising.

The investment assets of K-TOP REITS are, currently,
Gimpo Building (commercial facility) - 6, Geolpo-ro, Gimpo-si, Gyeonggi-do
Judies Taehwa (commercial facility) - 684, Jungang-daero, Busanjin-gu, Busan
Miwon Building (business facility) - 70, Gukjegeumyung-ro, Yeongdeungpo-gu, Seoul
Hwajeong Building (business facility) - 72, Hwajung-ro, Deogyang-gu, Goyang-si, Gyeonggi-do
Wanjeong Building (business facility) - 649, Wondang-daero, Seo-gu, Incheon
Seocho Building (etc.) - 58, Banpo-daero 4-gil, Seocho-gu, Seoul
Pangyowon Apelbaum (etc.) - 199, Sanun-ro, Bundang-gu, Seongnam-si, Gyeonggi-do

Macquarie Infrastructure - Do you look for a stable stock?

Macquarie Infrastructure - Do you look for a stable stock?
http://www.macquarie.com/mgl/mkif/kr
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20110531000053

Macquarie Korea Infrastructure Fund (MKIF) is a private infrastructure fund and the largest infrastructure fund in Korea that comprises of infrastructure assets.

The portfolio consists of the constructing and operating infrastructures such as toll roads, bridges, and tunnels. The purpose of MKIF is to make profits and distribute profits to shareholders. If you look at the MKIF chart below, dosen't it seem like it is a bit different from other stocks' chart?

The stock price, which has decreased from the offering price, now draws a constant  right-upward graph after finished a boring sideway drifting period. The reason why MKIF is steadily popular is that MKIF can hedge the inflation throughout the private infra fee that reflects the annual inflation rate.

This is the portfolio of MKIF.

http://www.macquarie.com/mgl/mkif/kr/about-mkif/investment-portfolio

MKIF distributes profits from investing in and operating the above assets. The dividend rate is 5.6% - 5.9%.

PSTEC - leads the smart grid

PSTEC - leads the smart grid
http://www.pstec.co.kr
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20160513004040

As we covered previously, the era that produces energy in the local area and consumes energy also in the local area comes soon. For this era, I think we need to develop the field of industries that are Energy Storage System (ESS) and smart grid altogether.

Generating electricity by using solar and wind power is irregular so that we have to maximize the efficiency of that throughout diverse electricity producers and electricity consumers who communicate each other bidirectionally to overcome the irregularity.

So I think the demand of Advanced Metering Infrastructure (AMI) that is produced by PSTEC will increase a lot. And PSTEC has provided AMIs to KEPCO, and they also had provided AMIs for a consortium of Jeju test site that is a kind of a smart grid model complex.

Yungjin Pharm - develops COPD and rheumatoid arthritis medicine

Yungjin Pharm - develops COPD and rheumatoid arthritis medicine
http://www.yungjin.co.kr
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20160428000982


COPD is an abbreviation for Chronic Obstructive Pulmonary Disease and a category of a disease that blocks the respiratory tract causing lower the speed of the air in the lungs without any other pulmonary diseases or cardiac diseases. As COPD gets more severe, the number of pulmonary alveoli under the terminal bronchiole increases and pulmonary alveoli wall breaks, which is called pulmonary emphysema. We use the term COPD when we can't discriminate the two symptoms.

It is known that more than 90% of the causes of COPD are due to smoking. Air pollution, congenital diseases, and respiratory infections also account for the remaining 10%. COPD is the world's 4th disease and 7th disease in Korea in terms of death rate. The world market capitalization for COPD has been estimated to reach 26.9 billion USD (31.5 trillion KRW) by 2017.
http://www.medgadget.com/2015/06/asthma-and-copd-drug-market-global-industry-analysis-market-size-share-trends-growth-and-forecasts-2010-2017.html

Rheumatoid arthritis is known to occur in around 0.8% of the adult population. There is no way to prevent or cure this disease, but we can slow down the progress. The global market for rheumatoid arthritis medicine is expected to reach 80 billion USD (93.9 trillion KRW) by 2020.
http://www.prnewswire.com/news-releases/rheumatoid-arthritis-market-to-2020---a-crowded-market-characterized-by-modest-growth-300059888.html

Below is the development schedule for COPD and rheumatoid arthritis medicine of Yungjin Pharm.

Development Research for COPD medicine (YPL-001)
- US clinical IND approval (2013. 04)
- Completed US Phase 1 clinical trial (SAD) (2013. 07)
- Completed US Phase 1 clinical trial (MAD) (2014. 02)
- Completed US Phase 2 clinical trial (PoC) US SAB meeting (2014. 01)
- US Phase 2 clinical trial (PoC) approval (2014. 10)
- Registration of US clinical trial (PoC) examination information (ClinicalTrials.gov, 2014. 10)
- Completed of Kick-off-meeting of US Phase 2 clinical trial (PoC) (2014, 10)
- Completed US Phase 2 clinical trial (PoC) IRB approval (2014. 12, 2015 02)
- US Phase 2 clinical trials (PoC) Selected as a new phase drug development project (2015. 01; 3.7 billion KRW)
- US Phase 2 clinical trial (PoC) clinical initiation meeting (2015 03)
- US Phase 2 clinical trial (PoC) is in progress (2016 04 - present)

Development Research for rheumatoid arthritis medicine (YRA-1909)
- Natural product research to push into the US market (2014. 12 - 2019. 11, Ministry of Trade, Industry and Energy: 5 years 3.5 billion KRW)
- Completed mass production study
- Secured GAP mass cultivation site (3,300 square meter) and cultivation: Jangheung-gun, Jeollanam-do
- Research on ensuring equality of raw materials by origin
- Ingredient research (separation, purification etc.)
- Identification of three new ingredients (preparing for patent application)
- selected government task by Ministry of Trade, Industry and Energy (2014 04)
- Production of raw materials and nonclinical toxicity test (2015 02 - present)
- Domestic Phase 2 clinical trial approval (2015.12) and preparations to proceed (present)


Competitive Products for COPD medicine

As you can see the above, most of the treatments are required to be inhaled. The problem is that when the drug is inhaled, the drug delivery to the deep lungs is not very successful. Drug efficacy is only about relieving symptoms.

In contrast, COPD medicine from Yungjin Pharm is a natural-based treatment extracted from Mountain spike speedwell so that patients can easily take it. This medicine has the advantage that the drug acts on the entire lung effectively and aims to function as a cure agent instead of a symptom reliever.


Competitive products for rheumatoid arthritis
You should inject new rheumatoid drugs below as you can read.
- Etanercept: 25 mg by subcutaneous injection twice a week
- Infliximab: 3 to 5 mg / kg by intravenous injection at 0, 2, 6 week of administraton and every 2 months thereafter
- Adilmumap: 40 mg by subcutaneous injection once every two weeks

On the other hand, YRA-1909 from Yongjin Pharm is a new drug based on a naturally extracted from the leaves of Stauntonia hexaphylla (Thunb) Decne. Of course, the effect is expected to be better than Tofacitinib or Etanercept.


If you are a doctor or a patient, which medicine would you prescribe or take?

Semes - a company for semiconductors and display-manufacturing-machines

Semes - a company for semiconductors and display-manufacturing-machines
https://www.semes.com

Semes manufactures and supplies various machines that are required to make display panels and semiconductors. They have a goal to get in world's top 5 equipments manufacturers with proprietary technology and manufacturing competitiveness. I hope the company can achieve this dream.


1. Semiconductor manufacturing equipment

Photo process track equipment (LOZIX) that is a kind of pre-process machine, washing equipment (BLUEICE, IRIS), etching equipment (MICHELAN OX), Die Bonder, Probe Station, Saw & Sorter, Test Handler that are post-process machine. Moreover, they have been designing wafer fault detectors and automated distribution system.


2. Display panel manufacturing equipment

Coater Full Line is a facility for drying, coating, and developing when producing TFT-LCD, and it is great at drying, coating, and transferring LCD panels. Z Printing is one of Ink-jet Printing System that are used to make LCD panels at C/F and Cell & Module process. And when they make OLED panel, it is used for pattern formation and sealing process. I should find more about Z Printing, however, it is interesting, because this equipment can be applied to make OLED, which is recognized as a next generation display.


Semes is the number one semiconductor equipment manufacturer in South Korea and has achieved annual sales of 1.1 trillion won in 2015.
I think that it is an achievable goal that this company can be one of top 5 equipment companies in the world.

OrientBio - provides experimental animials and developes hair growth solution

OrientBio - provides experimental animials and developes hair growth solution
(Stock code: 002630)
http://www.orient.co.kr
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20160215000464

This company provides many experimental animals to pharmaceutical companies and life science institutes. Also, this company is in Phase 1 clinical trial to develop a hair growth solution, which is named OND-1.


1. Providing experimental animals

OrientBio produces and provides rodents for making vaccine and mid or large-sized experimental animals like beagles. Rodents are derived from one of big experimental animal producer, Charles River Laboratories, in USA, and beagles have been produced and provided based on a partnership with a company Covance.

OrientBio also has a plan to provide experimental primates, cuz the demand primates has been increasing in South Korea, and there is no domestic primates provider. In addition, experimental primates would be essential for the process of bio-similar developments so that the plan to produce and provide high quality of experimental primate is a good try.


2. Development of hair growth solution

There are only two FDA-approved hair growth medicines in the market. Rogaine (5% Minoxidil, percutaneous medication) and Propecia (1 mg Finasteride, oral medication) are those medicine.

The size of hair related market is literally huge as you know. It is estimated that the world size of hair market is around 83.1 billion dollars in 2016.
http://www.statista.com/statistics/254608/global-hair-care-market-size

The effectiveness of a hair growth solution from OrientBio, OND-1, is better than Rogaine. I would say that when Phase I clinical trial can be finished with the final and successful product launch, Profecia may be replaced with OND-1 in the market.

Here are a time table for clinical trial below.
   <Domestic Phase 1 clinical trial>
2014 Dec: Try with 20% Velesco solution and test method
2015 Mar: Submit new clinical test report
2015 May: Expected clinical license in South Korea
2015 Nov: Clinical Phase 1 (Clinical IRB in Bundang Hospital, Seoul, South Korea)
2016 the first half: Complete Phase 1 clinical trial in Korea
   <Domestic Phase 2a clinical trial>
2016 Jun - 2016 Dec: Accepted 2 clinical trials in Korea
   <USA Phase 2b clinical trial>
2017 Feb - : Conversion and optimization with MN (animal experiment, 4 weeks application observation)
- 2018 Feb: Target goal of medication efficiency (compare with minoxidil), clinical trial for patients with hair losing patients.

I hope that the development of hair growth solution OND-1 from OrientBio would be successful so that thin hair people could have dense hair cuz the effectiveness of Rogaine is not that good, and they could ease the financial burden to buy Profecia (2 dollars per a tablet) soon. Lol

G-SMATT - produces unique smart glasses in the world.

G-SMATT - produces unique smart glasses in the world.
http://www.g-smatt.com

This company is a mother company of G-SMATT GLOBAL that was introduced yesterday.
Smart glasses produced from this company will be added on the inside of the pre-installed glasses.

For that reason, we can get several subsidiary but crucial advantages from the smart glasses allowing us to display and watch digital contents from the inside or outside of the building that is one of major goals.

Smart glasses from G-SMATT
1. leave the transparency of glasses high
2. don't require a lot of installment space
3. increase endurance of the original glasses
4. prevent ultra violet (UV) rays, block noisy sound, and insulate heat

The representative advantages are listed. Search around the other advantages (such as more colorful than other digital signage products or more available contents) on the Internet :)

I think smart glasses from G-SMATT is the real best among any other LED for digital signage.
Competitors of G-SMATT use other types of digital signage like LET Panel Type, Linear Type, or Metal Fabric Type, so that you guys would admit that G-SMATT is very competitive, if you notice what the other types are.

The next clip is a demonstration video.

https://www.youtube.com/watch?v=B9Upq4gj_Cw

I don't know how can I trade unlisted stocks.
I have no idea how the price would be decided.
I've heard that the price would be made by what people roughly call in the market. That is why negotiation is important to trade unlisted stocks.
The current price of G-SMATT is around 300 dollars, maybe.

This company would be listed in the end of 2016. If I would buy stock of G-SMATT, I would buy it after the listing, cuz I barely know about unlisted stocks.

Anyway, if I keep interacting with unlisted stocks like in this way, I wouldn't miss a great chance to make advanced purchasing in the future :)

G-SMATT GLOBAL - installs smart glasses lighting cities.

G-SMATT GLOBAL - installs smart glasses lighting cities.
(Stock code: 114570)
http://www.g-smattglobal.com/home/?lang=en
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20160512003957

This company constructs smart glasses on the inside of large glass surface of buildings.

Smart glasses, here, mean that a product visualizing digital images or texts into LED signal.

Korea government will revise the Outdoor Advertisement Act to allow like this smart glass on the surface of buildings within 2016, indicating that G-SMATT GLOBAL could get a benefit from the revised act.

Also, the smart glasses are exclusively produced by G-SMATT GLOBAL's parent company, G-SMATT, so that G-SMATT GLOBAL will be more predominance in competition in the market achieving a constant and high business profit rate for long.

https://www.youtube.com/watch?v=OpsOLMDZ3BA